Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.45747 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.49042 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.42575 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.41363 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.74433 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.5274 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.12434 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.73167 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.56292 | 79 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.49652 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.53245 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.34282 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.55686 | 79 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.5913 | 80 |